ESR1 and breast cancer: [68Ga]RM2 positron emission tomography (PET)/computed tomography (CT) has shown to be a promising imaging method for primary breast cancer (BC) with positive estrogen receptor (ER) status, but it has not been tested for visualization of metastasized recurrent or progressive BC.